Screening for MEN1 mutations in patients with atypical endocrine neoplasia

Alan P B Dackiw, Gilbert J. Cote, Jason B. Fleming, Pamela N. Schultz, Pamela Stanford, Rena Vassilopoulou-Sellin, Douglas B. Evans, Robert F. Gagel, Jeffrey E. Lee

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Background. Most patients from typical multiple endocrine neoplasia type 1 (MEN 1) kindreds harbor mutations in the MEN-1 gene, MEN1. We hypothesized that some patients with atypical endocrine neoplasia would also have mutations in MEN1. Methods. DNA sequencing analysis of mutations in the coding region of MEN1 was performed with genomic DNA obtained from peripheral blood lymphocytes in a total of 21 patients who had: typical MEN 1 (n = 8), clinical features suggestive of MEN 1 but without a family history of endocrinopathy (n = 7), and atypical endocrine neoplasia and a family history of endocrinopathy suggestive of MEN 1 (n = 6). Results. All 8 patients with typical MEN 1 had mutations in MEN1. None of the 7 patients with features of MEN 1, but without a family history of endocrinopathy, had a MEN1 mutation. In contrast, 4 of 6 patients with atypical endocrine neoplasia that included components of MEN 1 and a family history of endocrinopathy had mutations in MEN1, including 2 patients with pheochromocytoma. Conclusions. Genomic mutations in MEN1 may frequently be identified in patients with atypical endocrine neoplasia, especially in the setting of a family history of endocrinopathy. Atypical presentations of MEN 1 may include pheochromocytoma.

Original languageEnglish (US)
Pages (from-to)1097-1104
Number of pages8
JournalSurgery
Volume126
Issue number6
DOIs
StatePublished - 1999

Fingerprint

Multiple Endocrine Neoplasia Type 1
Mutation
Neoplasms
Pheochromocytoma

ASJC Scopus subject areas

  • Surgery

Cite this

Dackiw, A. P. B., Cote, G. J., Fleming, J. B., Schultz, P. N., Stanford, P., Vassilopoulou-Sellin, R., ... Lee, J. E. (1999). Screening for MEN1 mutations in patients with atypical endocrine neoplasia. Surgery, 126(6), 1097-1104. https://doi.org/10.1067/msy.2099.101376

Screening for MEN1 mutations in patients with atypical endocrine neoplasia. / Dackiw, Alan P B; Cote, Gilbert J.; Fleming, Jason B.; Schultz, Pamela N.; Stanford, Pamela; Vassilopoulou-Sellin, Rena; Evans, Douglas B.; Gagel, Robert F.; Lee, Jeffrey E.

In: Surgery, Vol. 126, No. 6, 1999, p. 1097-1104.

Research output: Contribution to journalArticle

Dackiw, APB, Cote, GJ, Fleming, JB, Schultz, PN, Stanford, P, Vassilopoulou-Sellin, R, Evans, DB, Gagel, RF & Lee, JE 1999, 'Screening for MEN1 mutations in patients with atypical endocrine neoplasia', Surgery, vol. 126, no. 6, pp. 1097-1104. https://doi.org/10.1067/msy.2099.101376
Dackiw APB, Cote GJ, Fleming JB, Schultz PN, Stanford P, Vassilopoulou-Sellin R et al. Screening for MEN1 mutations in patients with atypical endocrine neoplasia. Surgery. 1999;126(6):1097-1104. https://doi.org/10.1067/msy.2099.101376
Dackiw, Alan P B ; Cote, Gilbert J. ; Fleming, Jason B. ; Schultz, Pamela N. ; Stanford, Pamela ; Vassilopoulou-Sellin, Rena ; Evans, Douglas B. ; Gagel, Robert F. ; Lee, Jeffrey E. / Screening for MEN1 mutations in patients with atypical endocrine neoplasia. In: Surgery. 1999 ; Vol. 126, No. 6. pp. 1097-1104.
@article{faf1ac020ad14fd09a40d5c53d634aff,
title = "Screening for MEN1 mutations in patients with atypical endocrine neoplasia",
abstract = "Background. Most patients from typical multiple endocrine neoplasia type 1 (MEN 1) kindreds harbor mutations in the MEN-1 gene, MEN1. We hypothesized that some patients with atypical endocrine neoplasia would also have mutations in MEN1. Methods. DNA sequencing analysis of mutations in the coding region of MEN1 was performed with genomic DNA obtained from peripheral blood lymphocytes in a total of 21 patients who had: typical MEN 1 (n = 8), clinical features suggestive of MEN 1 but without a family history of endocrinopathy (n = 7), and atypical endocrine neoplasia and a family history of endocrinopathy suggestive of MEN 1 (n = 6). Results. All 8 patients with typical MEN 1 had mutations in MEN1. None of the 7 patients with features of MEN 1, but without a family history of endocrinopathy, had a MEN1 mutation. In contrast, 4 of 6 patients with atypical endocrine neoplasia that included components of MEN 1 and a family history of endocrinopathy had mutations in MEN1, including 2 patients with pheochromocytoma. Conclusions. Genomic mutations in MEN1 may frequently be identified in patients with atypical endocrine neoplasia, especially in the setting of a family history of endocrinopathy. Atypical presentations of MEN 1 may include pheochromocytoma.",
author = "Dackiw, {Alan P B} and Cote, {Gilbert J.} and Fleming, {Jason B.} and Schultz, {Pamela N.} and Pamela Stanford and Rena Vassilopoulou-Sellin and Evans, {Douglas B.} and Gagel, {Robert F.} and Lee, {Jeffrey E.}",
year = "1999",
doi = "10.1067/msy.2099.101376",
language = "English (US)",
volume = "126",
pages = "1097--1104",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Screening for MEN1 mutations in patients with atypical endocrine neoplasia

AU - Dackiw, Alan P B

AU - Cote, Gilbert J.

AU - Fleming, Jason B.

AU - Schultz, Pamela N.

AU - Stanford, Pamela

AU - Vassilopoulou-Sellin, Rena

AU - Evans, Douglas B.

AU - Gagel, Robert F.

AU - Lee, Jeffrey E.

PY - 1999

Y1 - 1999

N2 - Background. Most patients from typical multiple endocrine neoplasia type 1 (MEN 1) kindreds harbor mutations in the MEN-1 gene, MEN1. We hypothesized that some patients with atypical endocrine neoplasia would also have mutations in MEN1. Methods. DNA sequencing analysis of mutations in the coding region of MEN1 was performed with genomic DNA obtained from peripheral blood lymphocytes in a total of 21 patients who had: typical MEN 1 (n = 8), clinical features suggestive of MEN 1 but without a family history of endocrinopathy (n = 7), and atypical endocrine neoplasia and a family history of endocrinopathy suggestive of MEN 1 (n = 6). Results. All 8 patients with typical MEN 1 had mutations in MEN1. None of the 7 patients with features of MEN 1, but without a family history of endocrinopathy, had a MEN1 mutation. In contrast, 4 of 6 patients with atypical endocrine neoplasia that included components of MEN 1 and a family history of endocrinopathy had mutations in MEN1, including 2 patients with pheochromocytoma. Conclusions. Genomic mutations in MEN1 may frequently be identified in patients with atypical endocrine neoplasia, especially in the setting of a family history of endocrinopathy. Atypical presentations of MEN 1 may include pheochromocytoma.

AB - Background. Most patients from typical multiple endocrine neoplasia type 1 (MEN 1) kindreds harbor mutations in the MEN-1 gene, MEN1. We hypothesized that some patients with atypical endocrine neoplasia would also have mutations in MEN1. Methods. DNA sequencing analysis of mutations in the coding region of MEN1 was performed with genomic DNA obtained from peripheral blood lymphocytes in a total of 21 patients who had: typical MEN 1 (n = 8), clinical features suggestive of MEN 1 but without a family history of endocrinopathy (n = 7), and atypical endocrine neoplasia and a family history of endocrinopathy suggestive of MEN 1 (n = 6). Results. All 8 patients with typical MEN 1 had mutations in MEN1. None of the 7 patients with features of MEN 1, but without a family history of endocrinopathy, had a MEN1 mutation. In contrast, 4 of 6 patients with atypical endocrine neoplasia that included components of MEN 1 and a family history of endocrinopathy had mutations in MEN1, including 2 patients with pheochromocytoma. Conclusions. Genomic mutations in MEN1 may frequently be identified in patients with atypical endocrine neoplasia, especially in the setting of a family history of endocrinopathy. Atypical presentations of MEN 1 may include pheochromocytoma.

UR - http://www.scopus.com/inward/record.url?scp=0032756819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032756819&partnerID=8YFLogxK

U2 - 10.1067/msy.2099.101376

DO - 10.1067/msy.2099.101376

M3 - Article

C2 - 10598193

AN - SCOPUS:0032756819

VL - 126

SP - 1097

EP - 1104

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 6

ER -